Effect of total knee arthroplasty on metabolic syndrome

Journal of Arthroplasty

Volumn 25, Issue 7, 2010, Pages 1110-1114

  In, Yong ^a   Kong, Chae Gwan ^a   Kim, Jung Man ^a   Choi, Nam Yong ^a   Sur, Yoo Joon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Health; Metabolic syndrome; Physical activity; Total knee arthroplasty

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; KNEE SOCIETY SCORE; LIPID ANALYSIS; LOWER EXTREMITY ACTIVITY SCALE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RATING SCALE; TOTAL KNEE REPLACEMENT; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; OSTEOARTHRITIS, KNEE; PREVALENCE; PROSPECTIVE STUDIES;

EID: 77957254158     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2009.07.019     Document Type: Article

References (32)

1. Bennett K.J., Torrance G.W., Moran L.A., et al. Health state utilities in knee replacement surgery: the development and evaluation of McKnee. J Rheumatol 1997, 24:1796.
2. Birdsall P.D., Hayes J.H., Cleary R., et al. Health outcome after total knee replacement in the very elderly. J Bone Joint Surg Br 1999, 81:660.
3. Lavernia C.J., Guzman J.F., Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res 1997, 345:134.
4. Lingard E.A., Katz J.N., Wright E.A., et al. Predicting the outcome of total knee arthroplasty. J Bone Joint Surg Am 2004, 86:2179.
5. Lingard E.A., Katz J.N., Wright R.J., et al. Validity and responsiveness of the Knee Society clinical rating system in comparison with the SF-36 and WOMAC. J Bone Joint Surg Am 2001, 83:1856.
6. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473.
7. Bellamy N., Buchanan W.W., Goldsmith C.H., et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833.
8. Ethgen O., Bruyere O., Richy F., et al. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004, 86:963.
9. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683.
10. Lorenzo C., Okoloise M., Williams K., et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003, 26:3153.
11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143.
12. Stone N.J., Saxon D. Approach to treatment of the patient with metabolic syndrome: lifestyle therapy. Am J Cardiol 2005, 96:15E.
13. Singh G., Miller J.D., Lee F.H., et al. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care 2002, 8:S383.
14. Insall J.N., Dorr L.D., Scott R.D., et al. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989, 248:13.
15. Saleh K.J., Mulhall K.J., Bershadsky B., et al. Development and validation of a lower-extremity activity scale. Use for patients treated with revision total knee arthroplasty. J Bone Joint Surg Am 2005, 87:1985.
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486.
17. Lee C.M., Huxley R.R., Woodward M., et al. Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord 2008, 6:37.
18. Bo S., Gentile L., Ciccone G., et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev 2005, 21:515.
19. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356.
20. Grundy S.M., Brewer H.B., Cleeman J.I., et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433.
21. Marques-Vidal P., Mazoyer E., Bongard V., et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2002, 25:1371.
22. Bulwer B.E. Sedentary lifestyles, physical activity, and cardiovascular disease: from research to practice. Crit Pathw Cardiol 2004, 3:184.
23. Laaksonen D.E., Lakka H.M., Salonen J.T., et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002, 25:1612.
24. Kasapis C., Thompson P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005, 45:1563.
25. Bauman S., Williams D., Petruccelli D., et al. Physical activity after total joint replacement: a cross-sectional survey. Clin J Sport Med 2007, 17:104.
26. Woodruff M.J., Stone M.H. Comparison of weight changes after total hip or knee arthroplasty. J Arthroplasty 2001, 16:22.
27. Heisel C., Silva M., dela Rosa M.A., et al. The effects of lower-extremity total joint replacement for arthritis on obesity. Orthopedics 2005, 28:157.
28. Lachiewicz A.M., Lachiewicz P.F. Weight and activity change in overweight and obese patients after primary total knee arthroplasty. J Arthroplasty 2008, 23:33.
29. Esposito K., Ciotola M., Maiorino M.I., et al. Lifestyle approach for type 2 diabetes and metabolic syndrome. Curr Atheroscler Rep 2008, 10:523.
30. Ross R., Dagnone D., Jones P.J., et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000, 133:92.
31. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393.
32. Kim H.A., Kim S., Seo Y.I., et al. The epidemiology of total knee arthroplasty in South Korea. Rheumatology 2008, 47:88.